Table 2. Characteristics of included reviews.
N out of 35 | % | |
Year published | ||
2015 | 2 | 6% |
2016 | 3 | 9% |
2017 | 2 | 6% |
2018 | 3 | 9% |
2019 | 5 | 14% |
2020 | 5 | 14% |
2021 | 4 | 11% |
2022 | 6 | 17% |
2023 | 5 | 14% |
Geographic regions* | ||
Africa | 35 | 100% |
Asia | 13 | 37% |
Europe | 4 | 11% |
Latin America and the Caribbean | 12 | 34% |
North America | 4 | 11% |
Oceania | 1 | 3% |
Type of review | ||
Systematic review | 20 | 57% |
Systematic review and meta-analysis | 6 | 17% |
Systematic review and qualitative meta-synthesis | 1 | 3% |
Scoping review | 6 | 17% |
Review (type unspecified) | 2 | 6% |
SHRH domain† | ||
Helping people realise their desired family size (contraception and family planning; prevention and treatment of infertility) | 7 | 20% |
Ensuring the health of pregnant women/girls and their newborn infants (maternal and infant mortality; preventing complications in pregnancy, childbirth and postnatal period)) | 14 | 40% |
Preventing unsafe abortion | 1 | 3% |
Promoting sexual health and well-being (prevention of reproductive tract and sexually transmitted infections; HIV/AIDS; and promotion of sexual well-being and function)‡ | 23 | 66% |
Promoting SRHR in disease outbreaks (including prevention of sexual transmission, eg, of Zika or Ebola viruses) | 3 | 9% |
Promoting healthy adolescence for a healthy future (covering all SRHR outcomes, with a specific focus on adolescents) | 5 | 14% |
Preventing and responding to gender-based violence and harmful practices (intimate partner violence, domestic violence and sexual coercion/violence; and harmful practices (ie, female genital mutilation; child, early and forced marriage)) | 11 | 31% |
Covered at least two SRHR domains | 16 | 46% |
Number of primary studies included - mean (range, IQR) | 33 (5–127; 15, 50) | |
Methodology of included studies | ||
Quantitative only (of these, number limited to experimental designs) | 17 (5/17) | 49% |
Quantitative and qualitative (mixed methods) | 16 | 46% |
Qualitative only | 2 | 6% |
Main focal population(s) for interventions | ||
Both adults and youth§ | 17 | 49% |
Adults | 11 | 31% |
Youth | 3 | 9% |
Men and young men | 4 | 11% |
Extent to which studies collected data with men | ||
All/most | 16 | 46% |
Some | 13 | 37% |
Few/none | 4 | 11% |
Types of interventions | ||
Community education | 27 | 77% |
Health facility education | 19 | 54% |
Health facility service delivery approaches | 20 | 57% |
Community service delivery approaches | 21 | 60% |
Couples counselling | 19 | 54% |
Reaching men via their partners | 17 | 49% |
Mass media social mobilisation campaigns | 15 | 43% |
Gender transformative workshops | 12 | 34% |
School-based programmes | 13 | 37% |
Health facility strengthening/provider training | 9 | 26% |
Financial incentives | 11 | 31% |
Structural interventions | 7 | 20% |
mHealth interventions | 8 | 23% |
Workplace programmes | 2 | 6% |
Other | 121 | 34% |
Funding reported | ||
National Institutes of Health | 5 | 14% |
Bill & Melinda Gates Foundation | 3 | 9% |
USAID/PEPFAR | 5 | 14% |
WHO | 4 | 11% |
DFID/FCDO | 3 | 9% |
Other | 14 | 40% |
None reported | 12 | 34% |
Per United Nations regions.
WHO SRHR domains.
Excluding conditions not acquired sexually, for example, testicular and prostate cancers.
By ‘youth’/‘”young men’ is meant ages 10–24.
DFIDDepartment for International DevelopmentFCDOForeign, Commonwealth & Development OfficePEPFARU.S. President's Emergency Plan for AIDS ReliefSRHRsexual and reproductive health and rightsUSAIDUnited States Agency for International Development